Is Pharmaceutical Equity a Good Investment Right Now?

I've been diving into the pharmaceutical equity space lately, and I’m torn. On one hand, the ongoing innovation and need for new treatments could signal growth, but on the other hand, there’s all this talk about pricing regulations and market volatility. I’d love to hear what you all think about the current landscape. Are there specific companies or trends you're following? I’m particularly interested in how upcoming drug approvals or patent expirations could affect stock performance. Also, any insight on how broader economic factors might be impacting the sector would be super helpful. Anyone feeling bullish or bearish about this area? Let’s share some thoughts!